This article determines the incidence and cause of the complications commonly associated with metal-on-metal hip resurfacing implants and the proposed methods to prevent these complications. The literature available in PubMed…
The purpose of this study was to compare clinical and radiological outcomes of the first 191 fully porous-coated hip resurfacing arthroplasties with 96 hybrid hip resurfacing arthroplasties performed during the…
Narrowing of the femoral neck after metal-on-metal hip resurfacing arthoplasty has been reported as a common radiologic feature, although its significance is still unknown. This study reports the presence and…
Recent guidelines have suggested that routine postoperative care of patients with metal-on-metal hip prostheses should involve metal ion analysis. This study sought to investigate the relationship between bearing surface wear…
Resurfacing systems use press-fit, monoblock, cobalt chrome alloy acetabular sockets because of the material’s ability to withstand stresses while accommodating a large femoral head. Despite the widespread use of these…
The evolution of patient sporting activities after hip resurfacing has not yet been studied. A scoring algorithm to quantify sporting activity was developed to compare type of activity, frequency, duration,…
Total hip arthroplasty (THA) results in good outcomes in function and risk for revision in older patients. However, in young, active patients, it results in an increased rate of revision…
The results of metal-on-metal hip Conserve® Plus resurfacings with up to 14 years of follow-up with and without risk factors of small component size and/or large femoral defects were compared…
Consensus Statement Agree Agree with Minor Change Agree/Disagree in Part Disagree Goals of Treatment of Legg-Calvé-Perthes Disease 1. The primary long-term goal of treatment of Legg-Calvé-Perthes disease is to try…
Core decompression may be used as adjunct for treatment in some cases of Legg-Calvé-Perthes disease (LCPD). The primary application is for patients with onset at 12 years of age or…
